Integration of buprenorphine for substance-abuse treatment by HIV care providers

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue SUPPL. 1, 2011, Pages

  Friedland, Gerald ^a,b   Vlahov, David ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OPIATE ADDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNSPECIFIED SIDE EFFECT;

BUPRENORPHINE; HIV INFECTIONS; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS;

EID: 79951795311     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31820bc9ba     Document Type: Editorial

References (0)